0001104659-23-087284.txt : 20230803 0001104659-23-087284.hdr.sgml : 20230803 20230803161559 ACCESSION NUMBER: 0001104659-23-087284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20230803 DATE AS OF CHANGE: 20230803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thornton Peter J. CENTRAL INDEX KEY: 0001295432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 231140250 MAIL ADDRESS: STREET 1: TECHNOPATH LIFE SCIENCES PARK STREET 2: FORT HENRY, BALLINA CITY: CO. TIPPERARY STATE: L2 ZIP: V94 FF1P FORMER NAME: FORMER CONFORMED NAME: Thornton Peter DATE OF NAME CHANGE: 20040625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 tm2322778-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-01 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001295432 Thornton Peter J. C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 1 0 0 0 0 Stock Option (Right to Buy) 14.10 2023-08-01 4 A 0 33000 0 A 2033-08-01 ADSs 33000 33000 D Options shall vest in full on the earlier to occur of (a) August 1, 2024 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time. The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. /s/ Jerad G. Seurer, as Attorney-in-Fact 2023-08-03